Glaucoma News

Skye Bioscience has treated the first patient in its phase 2 study of SBI-100 ophthalmic emulsion, a CB1 agonist delivered as an eye drop to treat patients with elevated IOP, according to a company press release.

Factors including IOP, anterior chamber depth, cataract and short-term antidepressant exposure may increase primary angle-closure glaucoma risk, according to a review published in Optometry and Vision Science.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Richard A. Lewis, MD, of ViaLase discusses femtosecond laser image-guided high-precision trabeculotomy for the treatment of glaucoma.

A new study has shown that Orbis International’s online course helps nonophthalmic health care workers, who are already trained to recognize diabetic retinopathy, identify signs of glaucoma comparable to ophthalmologists.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Fritz H. Hengerer, MD, PhD, discusses the 7-year efficacy of cataract surgery with iStent inject and implantation of the Glaukos device as a stand-alone procedure.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Mariam Maghribi of Atia Vision and Shifamed, delivers updates from each company including developments for the OmniVu IOL system.

SAN FRANCISCO — Glaucoma programs can take notes from cataract services to improve detection, according to a speaker at the American Academy of Ophthalmology meeting.

NEW ORLEANS — Electroretinograms can help predict progression of diabetic retinopathy, age-related macular degeneration and glaucoma by providing objective information about visual function, according to Nate Lighthizer, OD, at Academy ’23.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Preeya K. Gupta, MD, discusses the potential of the SpyGlass Pharma IOL and bimatoprost delivery platform for lowering IOP long-term.

SAN FRANCISCO — When administering anti-VEGF treatments to patients with wet age-related macular degeneration, diabetic macular edema or retinal vein occlusion who have severe glaucoma, be mindful of the speed and volume of injections.